1.The First Case of Primary Retroperitoneal Mucinous Cystadenoma in Korea: A Case Report.
Byung Wook MIN ; Jong Man KIM ; Jun Won UM ; Eung Seok LEE ; Gil Soo SON ; Seung Joo KIM ; Hong Young MOON
The Korean Journal of Internal Medicine 2004;19(4):282-284
Primary mucinous cystic cystadenomas of the retroperitoneum are very rarely encountered, and there have been only about 30 cases reported in the literature. The histogenesis of primary mucinous cystadenomas is unclear. Most authors suggested that it develops through mucinous metaplasia in a pre-existing mesothelium-lined cyst. Complete surgical excision is the only treatment and it is required for the final diagnosis and cure. We present here a case report of a 38-year-old Korean woman with primary retroperitoneal cystadenoma. It was a thin-walled, multilocular cyst with a dominant loculus that measured 10.0 X 7.5 X 5.5 cm3 in size, and to the best of our knowledge, this is the first such case to be reported in in Korea.
Adult
;
Cystadenoma, Mucinous/*diagnosis/surgery
;
Female
;
Humans
;
Retroperitoneal Neoplasms/*diagnosis/surgery
2.Primary mucinous cystadenoma of the ileum.
Guo-biao LIANG ; Yi-ping LU ; Xiao-ke HUANG ; Ming SHI
Chinese Medical Journal 2009;122(23):2917-2919
Cystadenoma, Mucinous
;
diagnosis
;
pathology
;
surgery
;
Humans
;
Ileal Neoplasms
;
diagnosis
;
pathology
;
surgery
;
Male
;
Middle Aged
3.The diagnosis and therapy of pancreatic cystic tumors.
Chinese Journal of Surgery 2010;48(18):1409-1411
OBJECTIVETo discuss the surgical option and the treatment of complications of pancreatic cystic tumors.
METHODSFrom January 1997 to December 2009, 32 patients with pancreatic cystic tumors in our center were reviewed retrospectively. There were 6 male and 26 female, aging from 24 to 76 years. Of the 32 patients, 16 patients had serous cystadenoma, 9 patients had mucinous cystadenoma; 1 patients had mucinous cystadenocarcinoma; 4 patients had intraductal papillary mucinous neoplasms and 3 patients had pancreatic solid pseudopapillary neoplasms. Tumor located in pancreatic head in 12 patients and in pancreatic body and tail in 20 patients.
RESULTSAll patients received surgical treatment and there was no perioperative death. Pancreato-duodenectomy was performed in 10 patients, duodenum-preserving pancreatic head resection in 1 patient, distal pancreactomy in 13 patients, including laparoscopic distal pancreactomy in 2 patients, pancreatic tumor resection in 3 patients, middle segmental resection in 4 patients; 1 patients with mucinous cystadenocarcinoma received palliative surgery. Complication included gastroparesis in 3 patients and pancreatic fistula in 5 patients, and all recovered by conservative treatment. These 29 patients were followed up 4 - 120 months, 3 patients died from tumor metastasis or other disease within 4 to 34 months after surgery. Others were alive and there was no tumor recurrence or metastasis.
CONCLUSIONSCT scan should be the first choice of non-invasive examination for cystic pancreatic diagnosis. Positive and timely operation should be performed in the patient with cystic pancreatic tumor, and it acts as a cancer preventive treatment. The selection of surgical approach should be individualized, the principal of damage control surgery should be followed. Complications such as gastroparesis and pancreatic fistula should be paid more attention.
Adult ; Aged ; Cystadenoma, Mucinous ; diagnosis ; surgery ; Cystadenoma, Serous ; diagnosis ; surgery ; Female ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Pancreatic Neoplasms ; diagnosis ; surgery ; Retrospective Studies
4.Torus Hyperplasia of the Pyloric Antrum.
Chi Hun KIM ; Hye Seung HAN ; Sun Young LEE ; Byung Kook KIM ; In Kyung SUNG ; Moo Kyung SEONG ; Kyung Yung LEE
Journal of Korean Medical Science 2010;25(1):152-154
Primary or idiopathic hypertrophy of the pyloric muscle in adult, so called torus hyperplasia, is an infrequent but an established entity. It is caused by a circular muscle hypertrophy affecting the lesser curvature near the pylorus. Since most of the lesions are difficult to differentiate from tumor, distal gastrectomy is usually preformed to rule out most causes of pyloric lesions including neoplastic ones through a pathological study. A 56-yr-old man with a family history of gastric cancer presented with abdominal discomfort of 1 month duration. Upper gastrointestinal endoscopy showed a 1.0 cm sized irregular submucosal lesion proximal to the pylorus to the distal antrum on the lesser curvature. On colonoscopy examination, a 1.5 cm sized protruding mass was noticed on the appendiceal orifice. Gastrectomy and cecectomy were done, and histological section revealed marked hypertrophy of the distal circular pyloric musculature and an appendiceal mucocele. To the best of our knowledge, this is the first case of torus hyperplasia with appendiceal mucocele which is found incidentally.
Cystadenoma, Mucinous/diagnosis
;
Endoscopy, Gastrointestinal
;
Gastrectomy
;
Humans
;
Hyperplasia/diagnosis/pathology/surgery
;
Male
;
Middle Aged
;
Pyloric Antrum/*pathology/surgery
;
Tomography, X-Ray Computed
5.A Case of Primary Retroperitoneal Mucinous Cystadenoma Arising from the Retropancreatic Area.
Yoon Jeong NAM ; Tae Nyeun KIM ; Kook Hyun KIM ; Min Geun GU ; Jae Young LEE
The Korean Journal of Gastroenterology 2014;63(3):187-190
Primary retroperitoneal mucinous cystadenoma is an extremely uncommon tumor, even though mucinous cystadenoma often develops in the ovary and less frequently in the pancreas. A 21-year-old female was admitted to our hospital due to severe abdominal pain. A well-demarcated, oval shaped cystic tumor at the retropancreatic area with displacement of the pancreas and surrounding major vessels was observed on CT and MRI. Exploratory laparotomy was performed, and complete excision of the entire cyst was performed without complication. The pathologic finding was consistent with primary retropancreatic mucinous cystadenoma. To the best of our knowledge, this report is the first to describe a case of retropancreatic mucinous cystadenoma arising from the retropancreatic area in Korea.
Antibodies/metabolism
;
Cystadenoma, Mucinous/*diagnosis/pathology/surgery
;
Female
;
Humans
;
Magnetic Resonance Imaging
;
Mucin 5AC/immunology
;
Mucin-2/immunology
;
Ovarian Neoplasms/*diagnosis/pathology/surgery
;
Retroperitoneal Neoplasms/*diagnosis/pathology/surgery
;
Tomography, X-Ray Computed
;
Young Adult
6.Pancreatic mucinous cystadenoma of borderline malignancy associated with Clonorchis sinensis.
Jong Hwan CHOI ; Ji Hoon KIM ; Chung Ho KIM ; Young Kul JUNG ; Jong Eun YEON ; Kwan Soo BYUN ; Insun KIM
The Korean Journal of Internal Medicine 2015;30(3):398-401
No abstract available.
Animals
;
Biopsy
;
Clonorchiasis/diagnosis/*parasitology
;
Clonorchis sinensis/*isolation & purification
;
Cystadenoma, Mucinous/*parasitology/pathology/surgery
;
Foodborne Diseases/diagnosis/*parasitology
;
Humans
;
Magnetic Resonance Imaging
;
Male
;
Middle Aged
;
Pancreatectomy
;
Pancreatic Neoplasms/*parasitology/pathology/surgery
;
Seafood/*parasitology
;
Tomography, X-Ray Computed
;
Treatment Outcome
7.Diagnostic value of combining detection of human epididymis protein 4 and CA125 in patients with malignant ovarian carcinoma.
Min-jie WANG ; Jun QI ; Hai WANG ; Xue-xiang LI ; Bao-jun WEI ; Chao FU ; Jia GAO ; Bin-Bin HAN
Chinese Journal of Oncology 2011;33(7):540-543
OBJECTIVETo investigate the clinical value of combination of human epididymis protein 4 (HE4), CA125 and the Risk of Ovarian Malignancy Algorithm (ROMA) in diagnosis of ovarian carcinoma.
METHODSTo detect the serum concentration of HE4 using ELISA and CA125 using ECL in patients of ovarian carcinoma group (n = 119), borderline ovarian tumor group (n = 36), benign ovarian neoplasm group (n = 96) and female healthy control group (n = 53). The ROMA based on the serum level of CA125, HE4 and a woman's menopausal status was used to calculate the predicted probability (PP) and diagnostic results of ovarian cancers.
RESULTSThe receiver operating characteristic (ROC) analysis showed the cut-off value was 67.3 pmol/L (the AUC was 0.906, the sensitivity was 80.7% and specificity was 94.6%). The serum levels of HE4 and CA125 in the ovarian carcinoma group were significantly higher than that in the borderline ovarian tumor group, benign ovarian neoplasm group and female healthy control group (P < 0.01). The serum levels of CA125 and HE4 showed statistically no significant difference between the borderline ovarian tumor group and benign ovarian neoplasm group (P > 0.05). The levels of HE4 and CA125 were reduced significantly in ovarian patients after surgery therapy (P < 0.01). The sensitivity and specificity of HE4 + CA125 combination was 92.7% and 72.5%. The ROMA that can classify patients into high and low risk groups was established as 9.3% in premenopausal and 27.3% in postmenopausal women.
CONCLUSIONSHE4 is a helpful biomarker for ovarian carcinoma diagnosis. Biomarker combination of HE4 and CA125, and applying of the ROMA are helpful to improve the accuracy in diagnosis of ovarian cancers.
Adenocarcinoma, Mucinous ; blood ; diagnosis ; surgery ; Adolescent ; Adult ; Aged ; Aged, 80 and over ; Biomarkers, Tumor ; blood ; CA-125 Antigen ; blood ; Cystadenocarcinoma, Serous ; blood ; diagnosis ; surgery ; Cystadenoma, Serous ; blood ; diagnosis ; surgery ; Endometriosis ; blood ; diagnosis ; Female ; Humans ; Menopause ; Middle Aged ; Ovarian Neoplasms ; blood ; diagnosis ; surgery ; Proteins ; metabolism ; ROC Curve ; Sensitivity and Specificity ; Teratoma ; blood ; diagnosis ; surgery ; Young Adult